跳至主要内容
临床试验/CTRI/2017/10/009989
CTRI/2017/10/009989尚未招募3 期

Efficacy and Safety of Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Neonates less than or equal to 34 Weeks or less than or equal to 1800 gms: A Randomized Control Trial - BAP trial

Vivek Kumar Athwani0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Preterm neonates born at less than or equal to 34 weeks or birth weight less than or equal to 1800gms with hemodynemically significant Patent Ductus Arteriosus

排除标准

  • If any one of the following present
  • (1)Congenital heart disease which required PDA to maintain blood flow;
  • (2)Septic shock;
  • (3) Recent (within the previous 24 h) IVH,grade 3â??4;
  • (4) Urine output less than 1 ml/kg/h in preceding 8h;
  • (5) Serum creatinine more than 1.0mg/dl;
  • (6) Platelet count less than 50000/mm3;
  • (7) Hyper-bilirubinemia requiring exchange transfusion;
  • (8) necrotizing enterocolitis;
  • (9)Severe liver failure, defined as elevated liver enzymes SGOT/SGPT more than 2times, the upper limit of normal range;
  • (10)Previous treatment with paracetamol, ibuprofen or any COX inhibitor, for any purpose;
  • (11)Refusal of consent

研究者

发起方
Vivek Kumar Athwani

相似试验